‘Abortion pill’ soon to be available at no cost to NS women

Mifegymiso is a drug combination taken to medically terminate an early pregnancy (of up to 49 days). Beginning in November, Nova Scotia women with a valid health card and prescription will be able to get the drug without charge at pharmacies across the province.
“We’re supporting more choice for women when it comes to their reproductive health,” said Kelly Regan, minister responsible for the status of women. “This will ensure all Nova Scotia women have access to this option.”
The cost is estimated to be between $175,000 and $200,000 per year. Those with private insurance coverage will use that.
Physicians can prescribe Mifegymiso after an ultrasound rules out potential health risks and confirms gestational age.
The decision to provide the drug has been made to remove the requirement for a physician’s referral to obtain a surgical abortion at the Termination of Pregnancy Unit (TPU) at the Queen Elizabeth II Health Sciences Centre in Halifax.
Women will be able to refer themselves directly to the TPU, where they will be seen by a physician to begin the process.
The Nova Scotia Health Authority will also set up a phone line that women can call to make appointments and seek advice. The health authority will update women on progress and when self-referrals will be accepted, which is expected in the next few months.
“I’m pleased to see that government is acting to offer women in Nova Scotia more choice,” said Michelle Kelly, chair of the Nova Scotia Advisory Council on the Status of Women. “Providing universal coverage for Mifegymiso and improving access to abortion services are positive steps forward for Nova Scotia women.”
Lenore Zann, NDP Status of Women spokesperson, said, “
"The NDP Caucus is pleased to see the government take these important steps to improve access to reproductive health services in our province.
This change would not have been possible without the hard work of advocates, health care professionals, feminist organizations, and others.
We hope that the government will take further steps to ensure that women and trans people have timely access to Mifegymiso and other important reproductive and sexual health services."